Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients ...

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both ...

The video begins with a woman demonstrating to viewers the best way, in her opinion, to shovel snow. Lifting and scooping, ...

The current approach, which initiates medications and escalates to mechanical circulatory support, has not resulted in a ...

The myocardial infarction market is driven by the growing prevalence of cardiovascular diseases and advancements in diagnostics and treatments. Key factors include an aging population, ...

Taken at face value, the results would suggest that the three SGLT2 inhibitors are "virtually identical," according to ...

Hudson Regional Hospital’s Cardiac Catheterization Lab has earned NJ State Department of Health approval for STEMI ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study sought to determine the potential of extracellular vesicle (EV) microRNAs (miRNAs) to serve as ...

A study has revealed a significant link between a common pregnancy complication and early heart disease in women. The study ...

The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.